An interventional study of Wrist and Thumb orthosis in Carpal Tunnel Syndrome, Ulnar Nerve Injury and Rhizarthrosis, sponsored by TOPMED. Recruiting at 1 site in Canada. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2023-07-12.
Sponsored by TOPMED · Not applicable, Interventional, and Treatment
Among 16 studies in Carpal Tunnel Syndrome with a site in Canada — 4 open to participants now, 4 under way, none of them phase 3. Carpal Tunnel Syndrome · Canada.
Among the 16 studies in Carpal Tunnel Syndrome with a site in Canada, this one is the 14th largest by planned enrollment of the 15 interventional ones that give a count, is one of 2 that started in 2022, is one of 8 with no phase, and was the 14th registered.
589 studies on the registry are indexed under Carpal Tunnel Syndrome; 134 are open to participants now.
Browse Carpal Tunnel Syndrome studies →4 of the 16 studies in Carpal Tunnel Syndrome with a site in Canada are open now. Recruiting first, the newest first:
University of Manitoba · Sites in Canada
Ages 18+
Emily Krauss · Sites in Canada
Ages 18+ · Healthy volunteers
University of British Columbia · Sites in Canada
Ages 18+
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 73 Carpal Tunnel Syndrome studies recruiting now, 27 (37%) set no upper age limit and 37 (51%) stop at 75 or younger; 1 takes children under 18; 10 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 4 · Phase 3 1 · Phase 4 2
First in 2006; this study’s year is marked. 2 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 60 across 444 interventional studies indexed under Carpal Tunnel Syndrome.
Median enrollment 60 across the 15 interventional studies, 200 across the 1 observational. Of the 10 that completed or were terminated, 1 (10%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 16 has an industry lead sponsor. The 10 most frequent:
TOPMED is the lead sponsor of 12 studies on the registry; 3 are open to participants now.
TOPMED has 1 study filed under Carpal Tunnel Syndrome — fewer than ten, so there is no comparison to draw.
1 of the studies in Carpal Tunnel Syndrome with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07544914University of ManitobaEffects of Peripheral Repetitive Peripheral Magnetic Stimulation on Individuals With Elbow or Wrist Chronic Pain | 2027-08-30 |
Add it to your calendar (.ics) → With an account.
Among the 16 studies in Carpal Tunnel Syndrome with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
In order to offer a new product improving the healing and/or rehabilitation of injuries or injuries to the wrist and hand, Médicus is seeking to develop a new orthosis for the wrist and hand by 3D printing. This project will focus on the development of an orthosis related to carpal tunnel syndrome as well as droopy hand. Among the issues to be addressed in this development proposal, the investigators find: 1) Identification of the best methodology for taking digital impressions; design of an orthosis with the following characteristics: (i) no external attachment system, (ii) spiral design with a thumb ring, (iii) manufacturing by 3D printing and (iv) a cost of less than $150 ;3) Performing technical and clinical trials.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: Wrist and Thumb orthosis
Device: Wrist and Thumb orthosis
Custom 3D printed thumb and wrist orthosis
Change in pain during treatment from baseline at day 14
Pain measure via 1-5 rating, possible scores range from1 (no pain) to 5 (worst possible pain). Change = (Day 14 score - baseline score)
Time frame: Baseline and day 14
Difficulty in donning the orthosis
Yes/No question about having difficulty putting on the orthosis. No unit.
Time frame: Each day during 2 weeks of intervention
Comfort
Comfort measure via 1-5 rating, possible scores range from1 (worst possible comfort) to 5 (best possible comfort). No unit.
Time frame: Each day during 2 weeks of intervention
Weight satisfaction rating at baseline
Weight satisfaction measure via 1-5 rating, possible scores range from1 (worst possible satisfaction) to 5 (best possible satisfaction). No unit.
Time frame: Baseline
Satisfaction on ease of donning
Satisfaction measure via 1-5 rating on ease of donning, possible scores range from 1 (worst possible satisfaction) to 5 (best possible satisfaction). No unit.
Time frame: Baseline
Satisfaction on ease of donning
Satisfaction measure via 1-5 rating on ease of donning, possible scores range from 1 (worst possible satisfaction) to 5 (best possible satisfaction). No unit.
Time frame: Day 14 of intervention
Satisfaction on ease of doffing
Satisfaction measure via 1-5 rating on ease of doffing, possible scores range from 1 (worst possible satisfaction) to 5 (best possible satisfaction). No unit.
Time frame: Baseline
Satisfaction on ease of doffing
Satisfaction measure via 1-5 rating on ease of doffing, possible scores range from 1 (worst possible satisfaction) to 5 (best possible satisfaction). No unit.
Time frame: Day 14 of intervention
Functional disability evaluation of the upper member
Evaluation of disability of arm, shoulder and hand in activities of daily living via Quick Disability of arm, shoulder and hand (Quick DASH) (validated 11 elements 5-point rating). Possible scores range from 1 (No difficulty) to 5 (Incapacity to complete task). No unit.
Time frame: Baseline
Functional disability evaluation of the upper member
Evaluation of disability of arm, shoulder and hand in activities of daily living via Quick Disability of arm, shoulder and hand (Quick DASH) (validated 11 elements 5-point rating). Possible scores range from 1 (No difficulty) to 5 (Incapacity to complete task). No unit.
Time frame: Day 14 of intervention
Weight satisfaction rating at day 14 of intervention
Weight satisfaction measure via 1-5 rating, possible scores range from1 (worst possible satisfaction) to 5 (best possible satisfaction). No unit.
Time frame: Day 14 of intervention
aesthetic satisfaction rating at day 14 of intervention
Aesthetic satisfaction measure via 1-5 rating, possible scores range from1 (worst possible satisfaction) to 5 (best possible satisfaction). No unit.
Time frame: Day 14 of intervention
aesthetic satisfaction rating at baseline
Aesthetic satisfaction measure via 1-5 rating, possible scores range from1 (worst possible satisfaction) to 5 (best possible satisfaction). No unit.
Time frame: Baseline
material quality satisfaction rating at baseline
Material quality satisfaction measure via 1-5 rating, possible scores range from1 (worst possible satisfaction) to 5 (best possible satisfaction). No unit.
Time frame: Baseline
material quality satisfaction rating at day 14 of intervention
Material quality satisfaction measure via 1-5 rating, possible scores range from1 (worst possible satisfaction) to 5 (best possible satisfaction). No unit.
Time frame: Day 14 of intervention
Plan to share: No
No publications or documents are linked to this record.
Started May 2022 (actual). Primary completion is estimated for May 2024, 24 months after the start.
Of 251 non-industry interventional studies with no phase under Carpal Tunnel Syndrome, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 27. This study's planned 24 months is above that.
Counting every sponsor, half of 261 studies reached it within 12 months; a quarter within 7 and three quarters within 26.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
TOPMED